Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
50
NCT03628911
Study to Evaluate Tetanizing Burst Therapy in Patients Undergoing ICD Replacement
Phase: N/A
Role: Lead Sponsor
Start: Jan 1, 2018
Completion: Dec 1, 2020